Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaiser Laboratories Private Limited is an Indian pharmaceutical company that was incorporated in May 2011 and based in Villianur, Puducherry. The company primarily focused on the manufacture, supply, and trading of allopathic medicines, including tablets, capsules, and oral liquids. Its commercial product portfolio featured generic formulations such as Norlin-M, a combination of pregabalin, nortriptyline, and methylcobalamin used for the management of neuropathic pain. Other products in its catalog included cardiovascular treatments like atorvastatin and various nutritional supplements. Although registered as a private entity, the company's official regulatory status has been listed as 'Strike Off' by the Ministry of Corporate Affairs, indicating it is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaiser Laboratories.